Osteosarcoma and Ewing sarcoma are bone cancers that primarily affect children, teens, and young adults. Symptoms they share include bone pain, stiffness, and swelling at the tumor site. About 2% of ...

This feature explores evolving management strategies for bone sarcomas, highlighting multidisciplinary treatment approaches ...

Osteosarcoma is the earliest identified hominin cancer. It was found in a 1.7-million-year-old hominin fossil in South Africa and has also been identified in a 77-million-year-old dinosaur specimen. 1 ...

A research team at Johns Hopkins Medicine has created and trained a machine learning model to calculate percent necrosis (PN)—or, what percentage of a tumor is "dead" and no longer active—in patients ...

The SMAB will assist the Company in engaging with the US Food & Drug Administration (FDA) regarding the safety and efficacy of its lead immunotherapy product candidate, OST-HER2, for the treatment of ...

Although advances have been made in both surgical and medical management of patients with osteosarcoma, the overall survival of patients with osteosarcoma has remained constant, with no substantial ...

Osteosarcoma is a malignant neoplasm of the bone and is the most common histological form of primary bone cancer. It is most prevalent in children and young adults, as it is associated with the ...

While genetic sequencing has previously helped to uncover different subtypes of other cancers, like breast or skin cancer, for which those patients then receive targeted treatment personalised to ...

Osteosarcoma is the bone tumor that most commonly affects children, adolescents, and young adults. Before 1970, treatment primarily included surgical resection. However, the introduction of ...

The Osteosarcoma market presents opportunities in developing novel therapies, with over 25 companies working on 32+ drugs in the pipeline. There is strong focus on Phase III products like HS-20093, ...